Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling
2020 · Journal of Experimental & Clinical Cancer Research · 32 citations
https://doi.org/10.1186/s13046-020-01750-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
644
Citations
11
h-index
11
i10-index
Jianyang Xiang is an academic researcher from First Affiliated Hospital of Xi'an Jiaotong University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Ferroptosis and cancer prognosis & interferon and immune responses. The author has an h-index of 11, co-authored 15 publications.
ORCID: 0000-0001-5481-7196https://doi.org/10.1186/s13046-020-01750-4
https://doi.org/10.1038/s41419-022-04512-6
Click to start Chat